Skip to main content

Table 1 Summary of studies demonstrating a type I interferon signature in dermatomyositis muscle or blood

From: Type I interferon pathway in adult and juvenile dermatomyositis

Reference Array format (approximate number of genes) or other platform Tissue Sample size
Tezak and colleagues [4] Affymetrix HuFL (5,600) Muscle 4 JDM
Zhou and colleagues [6] cDNA (4,000) Muscle 6 PM, 4 DM
Greenberg and colleagues [7] Affymetrix U133A (16,000) Muscle 13 DM, 6 PM, 20 IBM
Raju and Dalakas [9] Affymetrix U133A (16,000) Muscle 3 DM, 4 IBM
Chen and colleagues [5] Affymetrix U133A (16,000) Muscle 31 JDM
Salajegheh and colleagues [8] Affymetrix U133A (16,000) Muscle 14 DM, 24 IBM, 38 PM/other
O'Connor and colleagues [16] Quantitative real-time RT-PCR Blood 14 JDM
Walsh and colleagues [24] Affymetrix U133A 2.0+ (38,500) Blood 12 DM, 11 PM, 13 IBM
Baechler and colleagues [23] Affymetrix U133A 2.0+ (38,500) Blood 10 DM, 2 JDM
Bilgic and colleagues [25] Quantitative real-time RT-PCR Blood 37 DM, 19 JDM
Liao and colleagues [26] Affymetrix U133A 2.0+ (38,500) Blood 24 DM, 12 PM, 15 IBM, 7 othera
  1. aIncludes some previously published data. DM, dermatomyositis; IBM, inclusion body myositis; JDM, juvenile dermatomyositis; PM, polymyositis.